Is Novo Nordisk Stock a Buy? [Yahoo! Finance]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: Yahoo! Finance
Obesity causes various chronic diseases and conditions, including type 2 diabetes. An estimated 830 million people have diabetes, with type 2 being the most common. Pharmaceutical giant Novo Nordisk (NYSE: NVO) built its business on insulin and has emerged as a leading innovator in GLP-1 agonists, relatively new drugs that treat obesity and type 2 diabetes by slowing digestion and reducing appetite. Researchers believe the GLP-1 agonist market could triple over the next decade to over $150 billion. Should investors buy Novo Nordisk stock? Here is what to know. The rampant success of GLP-1 agonists has been a windfall for Novo Nordisk. The company's trailing-12-month sales have almost doubled (up 81%) over the past three years, though this ha
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Holdings' earnings nearly doubled in 2024, despite Novo Nordisk's stock slump [Yahoo! Finance]Yahoo! Finance
- Novo Owner Targets More China Biotech Deals [Yahoo! Finance]Yahoo! Finance
- Novo Holdings nearly doubles earnings as Wegovy swells coffers [Yahoo! Finance]Yahoo! Finance
- Health Care Roundup: Market Talk [Yahoo! Finance]Yahoo! Finance
- Europe's pharma industry braces for tariffs as carve-out hopes fade [CNBC]CNBC
NVO
Earnings
- 2/6/25 - Beat
NVO
Sec Filings
- 3/31/25 - Form 6-K
- 3/10/25 - Form 6-K
- 2/27/25 - Form 6-K
- NVO's page on the SEC website